BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7961331)

  • 21. The female and the fragile X. A study of 144 obligate female carriers.
    Fryns JP
    Am J Med Genet; 1986; 23(1-2):157-69. PubMed ID: 3953644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation.
    Schneider A; Johnston C; Tassone F; Sansone S; Hagerman RJ; Ferrer E; Rivera SM; Hessl D
    Clin Neuropsychol; 2016 Aug; 30(6):929-43. PubMed ID: 27355445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral relationship between autism and fragile x syndrome.
    Demark JL; Feldman MA; Holden JJ
    Am J Ment Retard; 2003 Sep; 108(5):314-26. PubMed ID: 12901707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral and psychiatric disorders in adult male carriers of fragile X.
    Dorn MB; Mazzocco MM; Hagerman RJ
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):256-64. PubMed ID: 8150798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal study of the carrier testing process for fragile X syndrome: perceptions and coping.
    McConkie-Rosell A; Spiridigliozzi GA; Sullivan JA; Dawson DV; Lachiewicz AM
    Am J Med Genet; 2001 Jan; 98(1):37-45. PubMed ID: 11426454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of the physical, behavioral, and medical phenotype, including anthropometric measures, of females with fragile X syndrome.
    Hull C; Hagerman RJ
    Am J Dis Child; 1993 Nov; 147(11):1236-41. PubMed ID: 8237919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular/clinical correlations in females with fragile X.
    Sobesky WE; Taylor AK; Pennington BF; Bennetto L; Porter D; Riddle J; Hagerman RJ
    Am J Med Genet; 1996 Aug; 64(2):340-5. PubMed ID: 8844077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perception of facial expression and facial identity in subjects with social developmental disorders.
    Hefter RL; Manoach DS; Barton JJ
    Neurology; 2005 Nov; 65(10):1620-5. PubMed ID: 16301491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatial cognition in males with Fragile-X syndrome: evidence for a neuropsychological phenotype.
    Cornish KM; Munir F; Cross G
    Cortex; 1999 Apr; 35(2):263-71. PubMed ID: 10369098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Problem solving limitations among cytogenetically expressing fragile X women.
    Mazzocco MM; Hagerman RJ; Pennington BF
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):78-86. PubMed ID: 1605239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in research on the fragile X syndrome.
    Mazzocco MM
    Ment Retard Dev Disabil Res Rev; 2000; 6(2):96-106. PubMed ID: 10899802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring inhibitory deficits in female premutation carriers of fragile X syndrome: through eye movements.
    Shelton AL; Cornish K; Kraan C; Georgiou-Karistianis N; Metcalfe SA; Bradshaw JL; Hocking DR; Archibald AD; Cohen J; Trollor JN; Fielding J
    Brain Cogn; 2014 Mar; 85():201-8. PubMed ID: 24424424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal study of cognitive abilities and adaptive behavior levels in fragile X males: a prospective multicenter analysis.
    Fisch GS; Simensen R; Tarleton J; Chalifoux M; Holden JJ; Carpenter N; Howard-Peebles PN; Maddalena A
    Am J Med Genet; 1996 Aug; 64(2):356-61. PubMed ID: 8844080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired facial emotion recognition in individuals at ultra-high risk for psychosis and with first-episode schizophrenia, and their associations with neurocognitive deficits and self-reported schizotypy.
    Lee SY; Bang M; Kim KR; Lee MK; Park JY; Song YY; Kang JI; Lee E; An SK
    Schizophr Res; 2015 Jun; 165(1):60-5. PubMed ID: 25864951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential impact of the FMR1 gene on visual processing in fragile X syndrome.
    Kogan CS; Boutet I; Cornish K; Zangenehpour S; Mullen KT; Holden JJ; Der Kaloustian VM; Andermann E; Chaudhuri A
    Brain; 2004 Mar; 127(Pt 3):591-601. PubMed ID: 14736752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carrier detection and X-inactivation studies in the fragile X syndrome. Cytogenetic studies in 63 obligate and potential carriers of the fragile X.
    Nielsen KB; Tommerup N; Poulsen H; Jacobsen P; Beck B; Mikkelsen M
    Hum Genet; 1983; 64(3):240-5. PubMed ID: 6885068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for fragile X syndrome.
    Murray J; Cuckle H; Taylor G; Hewison J
    Health Technol Assess; 1997; 1(4):i-iv, 1-71. PubMed ID: 9414543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facial emotion perception by intensity in children and adolescents with 22q11.2 deletion syndrome.
    Leleu A; Saucourt G; Rigard C; Chesnoy G; Baudouin JY; Rossi M; Edery P; Franck N; Demily C
    Eur Child Adolesc Psychiatry; 2016 Mar; 25(3):297-310. PubMed ID: 26149605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When to tell and test for genetic carrier status: perspectives of adolescents and young adults from fragile X families.
    Wehbe RM; Spiridigliozzi GA; Heise EM; Dawson DV; McConkie-Rosell A
    Am J Med Genet A; 2009 Jun; 149A(6):1190-9. PubMed ID: 19449413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amygdala dysfunction in men with the fragile X premutation.
    Hessl D; Rivera S; Koldewyn K; Cordeiro L; Adams J; Tassone F; Hagerman PJ; Hagerman RJ
    Brain; 2007 Feb; 130(Pt 2):404-16. PubMed ID: 17166860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.